 TRILEPTAL
|
Novartis
|
| oxcarbazepina |
Anticonvulsivo |
| 300 mg comp.x 30 | $62.691,24 | (01/07/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $10.335,94 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $38.805,74 AF $23.885,50 |
|
|
|
|
| 300 mg comp.x 60 | $104.406,00 | (01/07/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $18.490,01 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $67.585,95 AF $36.820,05 |
|
|
|
|
| 600 mg comp.x 30 | $120.679,34 | (01/07/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $19.896,39 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $38.805,74 AF $81.873,60 |
|
|
|
|
| 600 mg comp.x 60 | $205.539,29 | (01/07/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $33.887,15 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $67.585,95 AF $137.953,34 |
|
|
|
|
| jbe.x 100 ml | $39.150,90 | (01/07/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $6.454,54 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $20.354,61 AF $18.796,29 |
|
|
|
|
| |
